for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Chr Hansen Holding A/S

CHRH.CO

Latest Trade

527.20DKK

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

497.10

 - 

758.00

As of on the Copenhagen Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Chr. Hansen: Jesper Brandgaard Buys 1000 Shares In Co

Oct 11 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::JESPER BRANDGAARD BUYS 1000 SHARES IN CO WITH PRICE DKK 505.45 PER SHARE.

Chr. Hansen Q4 EBIT Ex-Items At EUR 101.9 Mln, Below Expectations

Oct 10 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::Q4 REV EUR 305.9 MLN (REFINITIV POLL: EUR 312.38 MLN).Q4 EBIT EX-ITEMS EUR 101.9 MLN (REFINITIV POLL: EUR 105.15 MLN).Q4 NET PROFIT EUR 74.6 MLN (REFINITIV POLL: EUR 76.29 MLN).FOR 2019/20, ORGANIC REVENUE GROWTH IS EXPECTED TO BE 4-8%, WITH A NEUTRAL IMPACT FROM EUR PRICING.ORDINARY DIVIDEND FOR 2018/19 OF EUR 0.95 (DKK 7.07) PER SHARE, OR A TOTAL OF EUR 125 MILLION, IS PROPOSED.2019/20 THE GROUP GUIDANCE FOR THE FULL YEAR IS BELOW THE LONG-TERM AMBITION OF 8- 10%, PRIMARILY DUE TO AN EXPECTED WEAK Q1 AND A NEGATIVE DEVELOPMENT IN NATURAL COLOR RAW MATERIAL PRICES.OUTLOOK 2019/20: FREE CASH FLOW BEFORE ACQUISITIONS AND SPECIAL ITEMS IS EXPECTED TO BE AROUND EUR 190 MILLION.OUTLOOK 2019/20: THE EBIT MARGIN B.S.I. IS EXPECTED TO BE AROUND 29.5%.IN Q4, ORGANIC GROWTH CAME DOWN AS EXPECTED FOR ALL THREE BUSINESS AREAS DUE TO MACROECONOMIC CHALLENGES IN EMERGING MARKETS PRIMARILY IMPACTING FOOD CULTURES & ENZYMES AND NATURAL COLORS.CEO: "WE HAVE A CAUTIOUS OUTLOOK FOR 2019/20, GIVEN THE MARKET CHALLENGES WE ARE FACING".OUTLOOK 2019/20: IN Q1, THE ORGANIC GROWTH FOR THE GROUP IS EXPECTED TO BE FLAT TO LOW-SINGLE DIGIT DUE TO THE CHALLENGES FROM THE MACROECONOMIC VOLATILITY IN EMERGING MARKETS THAT HAVE IMPACTED THE BUSINESS IN THE SECOND HALF OF 2018/19,.

Chr. Hansen And Lonza’s JV Receives Anti-Trust Approvals And New Name

Aug 29 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::REG-CHR. HANSEN AND LONZA’S NEWLY BRANDED JOINT VENTURE, BACTHERA, RECEIVES ANTI-TRUST APPROVALS TO START CONTRACT MANUFACTURING OF LIVE BIOTHERAPEUTIC PRODUCTS.GOING FORWARD THE JOINT VENTURE WILL OPERATE UNDER THE NAME BACTHERA FROM ITS HEADQUARTERS IN BASEL, SWITZERLAND.BACTHERA WILL UPGRADE EXISTING FACILITIES IN HØRSHOLM, DENMARK.NOW APPROVED TO START OPERATIONS, THE COMPANY IS ENGAGING WITH ITS FIRST CUSTOMERS.OVERALL, EUR 90 MILLION WILL BE INVESTED, SHARED EQUALLY BETWEEN CHR. HANSEN AND LONZA, OVER A PERIOD OF THREE YEARS AND BACTHERA IS EXPECTED TO BE LARGELY SELF‐FUNDING AFTER THAT.BACTHERA WILL EQUIP NEW FACILITIES IN BASEL, SWITZERLAND TO SERVE PRE‐CLINICAL TO PHASE II PROJECTS.

Chr Hansen Board Member Buys 2,000 Shares In Co

June 28 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::BOARD MEMBER KRISTIAN VILLUMSEN BUYS 2,000 SHARES IN CO FOR DKK 610.00 PER SHARE.

Chr. Hansen Q3 EBIT Ex-Items Up YoY, Cuts Organic Growth Outlook

June 27 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::INTERIM REPORT SEPTEMBER 1, 2018 - MAY 31, 2019.SOLID SALES GROWTH AND PROFITABILITY IN Q3, BUT REDUCED ORGANIC GROWTH OUTLOOK FOR YEAR.Q3 REVENUE 302.0 MILLION EUROS VERSUS 282.7 MILLION EUROS.Q3 PROFIT 66.5 MILLION EUROS VERSUS 60.5 MILLION EUROS.Q3 EBIT BEFORE SPECIAL ITEMS 91.7 MILLION EURS VERSUS 84.0 MILLION EUROS.ORGANIC GROWTH OUTLOOK FOR 2018/19 IS ADJUSTED TO 7-8%, WHEREAS GUIDANCE ON EBIT IS UNCHANGED, GUIDANCE ON FCF IS ADJUSTED UPWARDS.SEES 2018/19 ORGANIC REVENUE GROWTH OF 7%-8%.IN Q3, ORGANIC GROWTH WAS 8%, AND EBIT BEFORE SPECIAL ITEMS INCREASED BY 9%.FY GUIDANCE FOR FOOD CULTURES & ENZYMES IS UNCHANGED, HEALTH & NUTRITION IS NOW EXPECTED TO GROW AROUND 10%.FY GUIDANCE ON EBIT MARGIN IS UNCHANGED.SEES 2018/19 EBIT MARGIN BEFORE SPECIAL ITEMS AROUND 29.5%.BASED ON CASH-FLOW GENERATION IN FIRST NINE MONTHS, BOARD DECIDED TO PAY OUT EXTRAORDINARY DIVIDEND TOTALING EUR 110 MILLION (DKK 6.24/SHARE).QTRLY EARNINGS PER SHARE EUR 0.50.CEO SAYS AS A RESULT OF THE LOWER THAN EXPECTED GROWTH MOMENTUM IN NATURAL COLORS AND ANIMAL HEALTH, AND A WEAKER GROWTH ENVIRONMENT IN EMERGING MARKETS, WE ARE ADJUSTING OUR FULL-YEAR OUTLOOK FROM 9-11% ORGANIC GROWTH FOR THE GROUP TO NOW 7-8% ORGANIC GROWTH.CEO SAYS GUIDANCE FOR FOOD CULTURES & ENZYMES IS UNCHANGED, HEALTH & NUTRITION IS NOW EXPECTED TO GROW AROUND 10%, AND NATURAL COLORS IS NOW EXPECTED TO GROW 4-5%.

Chr. Hansen: Board Member Buys 775 Shares In Co

April 8 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::BOARD MEMBER NIELS PEDER NIELSEN BUYS 775 SHARES IN CO FOR DKK 642.95 PER SHARE.

Kristian Villumsen Buys 1,500 Shares In Chr. Hansen

April 4 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::BOARD MEMBER KRISTIAN VILLUMSEN BUYS 1,500 SHARES IN CO WITH PRICE DKK 638.00 PER SHARE.

Chr.Hansen Q2 EBIT Ex-Items EUR 78.8 Million

April 3 (Reuters) - Chr Hansen Holding A/S <CHRH.CO>::REG-INTERIM REPORT SEPTEMBER 1, 2018 – FEBRUARY 28, 2019.REG-INTERIM REPORT SEPTEMBER 1, 2018 – FEBRUARY 28, 2019.THE OVERALL OUTLOOK FOR 2018/19 IS UNCHANGED COMPARED TO THE ANNOUNCEMENT OF OCTOBER 15, 2018..Q2 REVENUE EUR 283.7 MILLION VERSUS (REUTERS POLL: EUR 288 MILLION).Q2 EBIT EX-ITEMS EUR 78.8 MILLION (REUTERS POLL: EUR 80.8 MILLION).OUR EBIT MARGIN BEFORE SPECIAL ITEMS IN THE FIRST HALF OF THE YEAR INCREASED BY 0.8%-POINT AND WAS DRIVEN BY IMPROVED MARGINS IN ALL BUSINESS AREAS.“WE CONTINUED THE SOLID MOMENTUM, WITH FOOD CULTURES & ENZYMES DELIVERING STRONG ORGANIC GROWTH WITH AN INCREASING CONTRIBUTION FROM VOLUME IN Q2, WHICH WAS IN LINE WITH OUR EXPECTATIONS".SAYS PROGRESS IN FIRST HALF YEAR MAKES US CONFIDENT ABOUT OUR OVERALL OUTLOOK, WHICH IS MAINTAINED AND IN LINE WITH OUR LONG-TERM FINANCIAL AMBITION.

Chr. Hansen Sees Large Long-Term Potential In New JV - CFO

April 3 (Reuters) - Chr. Hansen <CHRH.CO>::CFO SAYS RANKING AS WORLD'S MOST SUSTAINABLE COMPANY HAS HAD A POSITIVE IMPACT ON ABILITY TO ATTRACT INVESTORS.CFO SAYS SEES LARGE LONG-TERM POTENTIAL IN NEW JOINT VENTURE WITH LONZA <<<LONN.S>>>.

Lonza Group And Chr. Hansen To Establish Joint Venture

April 2 (Reuters) - Lonza Group AG <LONN.S>::LONZA AND CHR. HANSEN IN JOINT VENTURE TO ACCELERATE MOMENTUM IN MICROBIOME.PHASED INVESTMENT OF APPROXIMATELY EUR 90 MILLION TO BE SHARED EQUALLY BETWEEN PARTNERS OVER THREE YEARS.LONZA GROUP - JV WILL BE A 50/50 CONTROLLED LEGAL ENTITY THAT WILL OPERATE FROM ITS HEADQUARTERS IN BASEL (CH) AND HAVE PRODUCTION FACILITIES IN DENMARK AND SWITZERLAND.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up